Norwegian version of this page

Psychiatric Molecular Genetics Group

The goal of The Psychiatric Molecular Genetics Group is to develop a strong research environment in molecular genetics of psychiatric disorders, and to provide a platform with molecular genetic services to research groups in psychiatric disorders.

About the group

The group is part of NORMENT and KG Jebsen Centre for Psychosis Research, which is a major collaborative effort studying clinical characteristics, neurocognitive functioning and brain biology of psychotic disorders.

The group’s current research aims are to perform molecular genetic analysis to increase the knowledge and expertise in psychiatric genetics and identify the molecular networks underlying psychiatric disease as well as to continually develop an organization to support psychiatric genetic studies with design and planning.


  • Identification of the hidden heritability of severe mental disorders
  • Identifying the polygenic basis of the human brain and neurodevelopmental disorders
  • Identifying causal variants in candidate regions
  • Human induced pluripotent stem cell (hiPSC) technologies in psychiatric molecular genetics
  • Prediction of longitudinal outcome and brain phenotype by polygenic scores
  • Identification of genetic loci associated with neurocognitive and MR phenotypes and implications for disease mechanisms in severe mental disorders
  • Biobanking, database, sample preparations, quality control


It is of vital importance to base genetic discovery on large samples, which is difficult to obtain without international collaboration. The Psychiatric Molecular Genetics Group participates in several large European studies of schizophrenia genetics, the SGENE-plus group (coordinated by deCODE, and including research groups as well as samples from England, Germany, Finland, Denmark, Iceland, Scotland) and Scandinavian Collaboration on Psychiatric Etiology (SCOPE),

Further, the Psychiatric Molecular Genetics Group is a member of the Psychiatric Genetics Consortium (PGC) which includes all GWAS studies in psychiatric genetics, as well as European IPSC Consortium for Neuropsychiatric Disorders  (EURICND).

Published Sep. 26, 2012 2:12 PM - Last modified June 29, 2018 9:52 AM